A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/451 (2006.01) A61K 31/4545 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2208836
Methods are disclosed utilizing DCL, a metabolic derivative of loratadine, for the treatment of allergic rhinitis, and other disorders, while avoiding the concomitant liability of adverse side-effects associated with other non- sedating antihistamines.
Des procédés utilisent la descarboéthoxyloratadine, un dérivé métabolique de loratadine, pour traiter la rhinite allergique et d'autres troubles tout en évitant le risque concomitant d'effets secondaires adverses associés aux autres antihistaminiques non sédatifs.
Aberg A.k. Gunnar
Mccullough John R.
Smith Emil R.
Osler Hoskin & Harcourt Llp
Sepracor Inc.
LandOfFree
Methods and compositions for treating allergic rhinitis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating allergic rhinitis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating allergic rhinitis and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2072714